Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statins and Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement
NCT05062239Recruiting
- Start
- Apr 2022
- Primary completion
- Feb 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of ulinastatin in Atrial fibrillation (AFib) (2 arms). Primary endpoints: Number of Participants with Postoperative Atrial Fibrillation - In-hospital up to 10 days, Number of Participants with Postoperative Atrial Fibrillation - Early up to 30 days and 1 more. Started Apr 2022; status: recruiting.
02
Drugs
ulinastatin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05062239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05062239.